1146 related articles for article (PubMed ID: 10813558)
1. Identification of kaempferol as a monoamine oxidase inhibitor and potential Neuroprotectant in extracts of Ginkgo biloba leaves.
Sloley BD; Urichuk LJ; Morley P; Durkin J; Shan JJ; Pang PK; Coutts RT
J Pharm Pharmacol; 2000 Apr; 52(4):451-9. PubMed ID: 10813558
[TBL] [Abstract][Full Text] [Related]
2. VERIFICATION OF AUTHENTICITY OF
Budeč M; Bošnir J; Racz A; Lasić D; Brkić D; Mosović Ćuić A; Kuharić Ž; Jurak G; Barušić L
Acta Clin Croat; 2019 Dec; 58(4):672-692. PubMed ID: 32595253
[No Abstract] [Full Text] [Related]
3. Extracts of Ginkgo biloba leaves inhibit monoamine oxidase.
White HL; Scates PW; Cooper BR
Life Sci; 1996; 58(16):1315-21. PubMed ID: 8614288
[TBL] [Abstract][Full Text] [Related]
4. Involvement of monoamine oxidase inhibition in neuroprotective and neurorestorative effects of Ginkgo biloba extract against MPTP-induced nigrostriatal dopaminergic toxicity in C57 mice.
Wu WR; Zhu XZ
Life Sci; 1999; 65(2):157-64. PubMed ID: 10416821
[TBL] [Abstract][Full Text] [Related]
5. Evidence that gingko biloba extract does not inhibit MAO A and B in living human brain.
Fowler JS; Wang GJ; Volkow ND; Logan J; Franceschi D; Franceschi M; MacGregor R; Shea C; Garza V; Liu N; Ding YS
Life Sci; 2000 Jan; 66(9):PL141-6. PubMed ID: 10698362
[TBL] [Abstract][Full Text] [Related]
6. [Determination of flavonoids in Ginkgo biloba L. leaves from different producing areas].
Wang H; Zhao GB; Liu SQ; Zheng JH
Zhongguo Zhong Yao Za Zhi; 2000 Jul; 25(7):408-10. PubMed ID: 12515221
[TBL] [Abstract][Full Text] [Related]
7. In vivo regulation of cerebral monoamine oxidase activity in senescent controls and chronically stressed mice by long-term treatment with Ginkgo biloba extract (EGb 761).
Pardon MC; Joubert C; Perez-Diaz F; Christen Y; Launay JM; Cohen-Salmon C
Mech Ageing Dev; 2000 Feb; 113(3):157-68. PubMed ID: 10714935
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic evaluation of Ginkgo biloba leaf extract-induced genotoxicity in L5178Y cells.
Lin H; Guo X; Zhang S; Dial SL; Guo L; Manjanatha MG; Moore MM; Mei N
Toxicol Sci; 2014 Jun; 139(2):338-49. PubMed ID: 24595819
[TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacokinetics and bioavailability studies of quercetin, kaempferol and isorhamnetin after oral administration of Ginkgo biloba extracts, Ginkgo biloba extract phospholipid complexes and Ginkgo biloba extract solid dispersions in rats.
Chen ZP; Sun J; Chen HX; Xiao YY; Liu D; Chen J; Cai H; Cai BC
Fitoterapia; 2010 Dec; 81(8):1045-52. PubMed ID: 20603197
[TBL] [Abstract][Full Text] [Related]
10. Characterization of
Ban C; Park JB; Cho S; Kim HR; Kim YJ; Bae H; Kim C; Kang H; Jang D; Shin YS; Kim DO; Kim H; Kweon DH
Molecules; 2020 Apr; 25(8):. PubMed ID: 32316426
[No Abstract] [Full Text] [Related]
11. Selective responses of three Ginkgo biloba leaf-derived constituents on human intestinal bacteria.
Lee HS; Kim MJ
J Agric Food Chem; 2002 Mar; 50(7):1840-4. PubMed ID: 11902921
[TBL] [Abstract][Full Text] [Related]
12. Screening and Identifying Antioxidative Components in Ginkgo biloba Pollen by DPPH-HPLC-PAD Coupled with HPLC-ESI-MS2.
Qiu J; Chen X; Netrusov AI; Zhou Q; Guo D; Liu X; He H; Xin X; Wang Y; Chen L
PLoS One; 2017; 12(1):e0170141. PubMed ID: 28095510
[TBL] [Abstract][Full Text] [Related]
13. Development of an ultra-fast liquid chromatography-tandem mass spectrometry method for simultaneous determination of seven flavonoids in rat plasma: Application to a comparative pharmacokinetic investigation of Ginkgo biloba extract and single pure ginkgo flavonoids after oral administration.
Wang T; Xiao J; Hou H; Li P; Yuan Z; Xu H; Liu R; Li Q; Bi K
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():173-181. PubMed ID: 28622621
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of intestinal and hepatic glucuronidation of mycophenolic acid by Ginkgo biloba extract and flavonoids.
Mohamed MF; Frye RF
Drug Metab Dispos; 2010 Feb; 38(2):270-5. PubMed ID: 19889883
[TBL] [Abstract][Full Text] [Related]
15. Interactions of pharmacokinetic profile of different parts from Ginkgo biloba extract in rats.
Guan H; Qian D; Ren H; Zhang W; Nie H; Shang E; Duan J
J Ethnopharmacol; 2014 Aug; 155(1):758-68. PubMed ID: 24953034
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a ginkgo biloba extract (EGb 761) in functional tests for monoamine oxidase inhibition.
Porsolt RD; Roux S; Drieu K
Arzneimittelforschung; 2000 Mar; 50(3):232-5. PubMed ID: 10758773
[TBL] [Abstract][Full Text] [Related]
17. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O
J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694
[TBL] [Abstract][Full Text] [Related]
18. An effective identification and quantification method for Ginkgo biloba flavonol glycosides with targeted evaluation of adulterated products.
Ma YC; Mani A; Cai Y; Thomson J; Ma J; Peudru F; Chen S; Luo M; Zhang J; Chapman RG; Shi ZT
Phytomedicine; 2016 Apr; 23(4):377-87. PubMed ID: 27002408
[TBL] [Abstract][Full Text] [Related]
19. Coumaroyl flavonol glycosides from the leaves of Ginkgo biloba.
Tang Y; Lou F; Wang J; Li Y; Zhuang S
Phytochemistry; 2001 Dec; 58(8):1251-6. PubMed ID: 11738417
[TBL] [Abstract][Full Text] [Related]
20. Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1.
Chang TK; Chen J; Yeung EY
Toxicol Appl Pharmacol; 2006 May; 213(1):18-26. PubMed ID: 16226778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
